Helus Pharma Inc. Common Stock
HELP
98 hedge funds and large institutions have $78.4M invested in Helus Pharma Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 20 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 16
8% less funds holding
Funds holding: 107 → 98 (-9)
38.7% less ownership
Funds ownership: 76.76% → 38.05% (-39%)
40% less capital invested
Capital invested by funds: $130M → $78.4M (-$52M)
45% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
+$1.84M |
| 2 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
+$847K |
| 3 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$75.9K |
| 4 |
CIBC World Market
Toronto,
Ontario, Canada
|
+$71.5K |
| 5 |
PI
PEAK6 Investments
Chicago,
Illinois
|
+$70K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.65M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$4.87M |
| 3 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$1.85M |
| 4 |
AIC
AWM Investment Company
New York
|
-$930K |
| 5 |
Corient Private Wealth
Miami,
Florida
|
-$41.4K |
HELP Hedge Fund Activity: Q2 2024 in Review
98 of the 6,939 institutional investors tracked by Wall St. Rank reported a position in Helus Pharma Inc. Common Stock (HELP) for Q2 2024, worth a combined $78.4M — down 40% from $130M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of HELP and 11 opened new positions — a net loss of 9 holders — while 16 trimmed existing stakes and 15 added.
The largest buyer was Rosalind Advisors, adding an estimated $1.84M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $5.65M sold.
- 98 institutional investors held Helus Pharma Inc. Common Stock (HELP) as of Q2 2024, down from 107 in Q1 2024.
- Funds reported $78.4M of Helus Pharma Inc. Common Stock stock for Q2 2024, down 40% quarter-over-quarter.
- 11 funds opened new Helus Pharma Inc. Common Stock positions in Q2 2024 and 20 closed out, a net change of -9 holders.
- The largest Helus Pharma Inc. Common Stock buyer in Q2 2024 was Rosalind Advisors, an estimated $1.84M added.
- The largest Helus Pharma Inc. Common Stock seller in Q2 2024 was Point72 Asset Management, an estimated $5.65M sold.
Based on aggregated 13F filings for Q2 2024.